https://frenchstemtoday.com/article/908726105-inokim-launches-the-world-s-first-electric-scooters-and-e-bikes-with-built-in-smart-connected-display French STEM Today en PressRelease 2026-04-28T21:29:45+00:00 INOKIM Launches the World's First Electric Scooters and E Bikes With Built In Smart Connected Display https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842602-inokim-dubai-collection-world-896x1200.jpeg https://frenchstemtoday.com/article/908703517-hasused-raises-3-8-million-through-fastercapital-to-build-a-trusted-marketplace-for-verified-second-hand-products French STEM Today en PressRelease 2026-04-28T21:15:08+00:00 HasUsed Raises $3.8 Million Through FasterCapital to Build a Trusted Marketplace for Verified Second-Hand Products https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24810037-fastercapital-logo2-2206x379.png https://frenchstemtoday.com/article/908733547-independent-research-firm-names-sbs-a-strong-performer-in-digital-banking-engagement-platforms-q2-2026 French STEM Today en PressRelease 2026-04-28T13:24:51+00:00 Independent Research Firm Names SBS a Strong Performer in Digital Banking Engagement Platforms, Q2 2026 https://frenchstemtoday.com/article/908712764-coave-therapeutics-to-unveil-oneaavtm-universal-capsid-at-asgct-2026-paving-the-way-for-third-generation-gene-therapy-vectors French STEM Today en PressRelease 2026-04-28T11:00:00+00:00 Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors https://ml-eu.globenewswire.com/media/b3d8ab3f-5292-4296-9ffa-7db27ba83e82/small/coave-tx-high-res-logo-1-png.png https://frenchstemtoday.com/article/908315825-influence-society-launches-ai-studio-to-scale-premium-content-production-for-luxury-hospitality-brands French STEM Today en PressRelease 2026-04-27T12:15:00+00:00 Influence Society Launches AI Studio to Scale Premium Content Production for Luxury Hospitality Brands https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841173-ai-studio2-4096x2286.jpeg https://frenchstemtoday.com/article/908381127-ose-immunotherapeutics-welcomes-fda-orphan-drug-designation-granted-to-pegrizeprument-vel-101-for-prevention-of-organ-rejection-in-heart-transplant French STEM Today en PressRelease 2026-04-27T05:30:00+00:00 OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://frenchstemtoday.com/article/908381134-ose-immunotherapeutics-se-f-licite-de-l-octroi-de-la-d-signation-de-m-dicament-orphelin-par-la-fda-du-pegrizeprument-vel-101-pour-la-pr-vention-du French STEM Today en PressRelease 2026-04-27T05:30:00+00:00 OSE Immunotherapeutics se félicite de l'octroi de la désignation de médicament orphelin par la FDA du pegrizeprument (VEL-101) pour la prévention du rejet d’organe dans la transplantation cardiaque https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/